Meloxicam
Product Images NDC 70934-476

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Meloxicam (NDC 70934-476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (0b0ded9b 1266 417c 867f 41800c993b92 01)

Image (0b0ded9b 1266 417c 867f 41800c993b92 01)
Chemical structure of Meloxicam showing its molecular framework, including a benzothiazine ring system with hydroxyl, methyl, and sulfonamide groups. The diagram depicts atoms and bonds characteristic of the active ingredient Meloxicam.*
FDA Label Image

Label (70934 476 60 Master Bottle Label Approval Rev A 01 20)

Label (70934 476 60 Master Bottle Label Approval Rev A 01 20)
Meloxicam Tablets USP 7.5 mg package label for 60 tablets by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes storage instructions to keep the product at 20° to 25°C and cautions to keep out of reach of children and to store in a dry place. The label also shows multiple NDC codes and placeholders for lot numbers and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.